This inventor holds 1 USPTO granted patent. Top assignee: Sequenom-Gemini Limted. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Rikard Henry Reneland
Introduction
Rikard Henry Reneland is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in the detection of heart failure. His innovative work has led to the development of novel reagents and methods that enhance the diagnosis of predisposition to left ventricular heart failure.
Latest Patents
Rikard holds 1 patent for his invention titled "Reagents and methods for detection of heart failure." This invention provides novel reagents, kits, and methods for diagnosing predisposition to left ventricular heart failure. The diagnostic approach is based on the analysis of polymorphic variants of genomic nucleic acid, as set forth in SEQ ID NO:1.
Career Highlights
Rikard is currently associated with Sequenom-Gemini Limited, where he continues to advance his research and innovations in the medical field. His work is pivotal in improving diagnostic techniques that can lead to better patient outcomes.
Collaborations
Rikard has collaborated with esteemed colleagues, including Lars Gunnar Ture Berglund and Gail Isabel Reid Adam. These collaborations have further enriched his research and contributed to the development of effective diagnostic methods.
Conclusion
Rikard Henry Reneland's contributions to the field of heart failure diagnostics exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in patient care and diagnostic accuracy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile